Literature DB >> 791267

Characterization of upFc, a fragment of human immunoglobulin G1 produced by pepsin in urea.

D M Parr, T Hofmann, G E Connell.   

Abstract

The digestion of human IgG1/K myeloma proteins with pepsin in the presence of 8 M-urea produces fragments that differ from those produced by aqueous peptic digestion, and from other characteristic immunoglobulin fragments. Fb'2, the larger urea/pepsin fragment, was previously shown to consist of the constant regions of the light chains, and the CH1 domains and hinge regions of the heavy chains. The smaller fragment, upFc, has now been characterized. After reduction, three peptides were released from fragment upFc. Amino acid sequencing, N- and C-terminal determinations and amino acid compositions have enabled these peptides to be identified as residues Ile-253 to Leu-306, residues Thr-307 to Asp-376 and residues Thr-411 to Gly-446 of the heavy chain. Fragment upFc therefore contains the entire Fc region, beginning at residue Ile-253, except for a 34-residue section from within the CH3-domain disulphide loop. Peptic digestion of IgG1/K proteins in 8M-urea therefore provides a method for isolating from gamma1 heavy chains five homogeneous peptides in good yield, which account for almost the entire constant region. Characterization of fragments Fb'2 and upFc has shown that the action of pepsin in urea is entirely different from that of aqueous pepsin. Two gamma1 heavy chains have been shown to differ in sequence at three positions from the sequence reported for protein Eu.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 791267      PMCID: PMC1163894          DOI: 10.1042/bj1570535

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  9 in total

1.  Separation of univalent fragments from the bivalent rabbit antibody molecule by reduction of disulfide bonds.

Authors:  A NISONOFF; F C WISSLER; L N LIPMAN; D L WOERNLEY
Journal:  Arch Biochem Biophys       Date:  1960-08       Impact factor: 4.013

2.  Fb'2, a new peptic fragment of human immunoglobulin G.

Authors:  D M Parr; G E Connell; D I Kells; T Hofmann
Journal:  Biochem J       Date:  1976-04-01       Impact factor: 3.857

3.  Studies on papain produced subunits of human gamma-G-globulins. II. Structures of peptides related to the genetic Gm activity of gamma-G-globulin Fc-fragments.

Authors:  N O Thorpe; H F Deutsch
Journal:  Immunochemistry       Date:  1966-07

4.  Products of the peptic digestion of human gamma-G-immunoglobulin.

Authors:  R Heimer; S S Schnoll; A Primack
Journal:  Biochemistry       Date:  1967-01       Impact factor: 3.162

5.  The use of penicillocarboxypeptidase-S1 in amino acid sequencing.

Authors:  A Hui; L Rao; A Kurosky; A Jones; S R Jones; G Mains; J W Dixon; A Szewczuk; T Hofmann
Journal:  Arch Biochem Biophys       Date:  1974-02       Impact factor: 4.013

6.  Application of sequenator analyses to the study of proteins.

Authors:  M A Hermodson; L H Ericsson; K Titani; H Neurath; K A Walsh
Journal:  Biochemistry       Date:  1972-11-21       Impact factor: 3.162

7.  The release of Fe' and pFc' fragments from human immunoglobulin G following enzymic digestion: a time study.

Authors:  H Bennich; M W Turner
Journal:  Biochim Biophys Acta       Date:  1969-03

8.  Quantitative procedures for use with the Edman-Begg sequenator. Partial sequences of two unusual immunoglobulin light chains, Rzf and Sac.

Authors:  O Smithies; D Gibson; E M Fanning; R M Goodfliesh; J G Gilman; D L Ballantyne
Journal:  Biochemistry       Date:  1971-12-21       Impact factor: 3.162

9.  The covalent structure of an entire gammaG immunoglobulin molecule.

Authors:  G M Edelman; B A Cunningham; W E Gall; P D Gottlieb; U Rutishauser; M J Waxdal
Journal:  Proc Natl Acad Sci U S A       Date:  1969-05       Impact factor: 11.205

  9 in total
  1 in total

1.  Fragments produced by digestion of human immunoglobulin G subclasses with pepsin in urea.

Authors:  D M Parr
Journal:  Biochem J       Date:  1977-08-01       Impact factor: 3.857

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.